Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis

被引：0
|
作者：
Mieraf Taddesse Tolla
Ole Frithjof Norheim
Solomon Tessema Memirie
Senbeta Guteta Abdisa
Awel Ababulgu
Degu Jerene
Melanie Bertram
Kirsten Strand
Stéphane Verguet
Kjell Arne Johansson
机构：
[1] University of Bergen,Department of Global Public Health and Primary Health Care
[2] Addis Ababa University,Department of Internal Medicine, School of Medicine
[3] Federal Ministry of Health (FMOH),Department of Global Health and Population
[4] Management Science for Health,undefined
[5] World Health Organization,undefined
[6] Harvard T.H. Chan School of Public Health,undefined
来源：
Cost Effectiveness and Resource Allocation | / 14卷
关键词：
Cost-effectiveness analysis; Cardiovascular disease; Ischemic heart disease; Stroke; Prevention; Treatment; Ethiopia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Cobiac, Linda J.
    Magnus, Anne
    Barendregt, Jan J.
    Carter, Rob
    Vos, Theo
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [32] THE POLYPILL IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: COST-EFFECTIVENESS IN THE DUTCH POPULATION
    Van Gils, P. F.
    Hamberg-Van Reenen, H. H.
    Over, E.
    de Wit, G. A.
    van den Berg, M.
    Schuit, A. J.
    Engelfriet, P. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A381 - A381
  • [33] Cost-effectiveness of cardiovascular prevention programs in Spain
    Plans-Rubio, P
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (02) : 320 - 330
  • [34] Cost-Effectiveness of Cardiovascular Disease Spending
    Miller, George
    Cohen, Joshua T.
    Roehrig, Charles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2123 - 2124
  • [35] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. CIRCULATION, 2016, 134
  • [36] Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
    Mujwara, Deo
    Kintzle, Jen
    Di Domenico, Paolo
    Busby, George B.
    Botta, Giordano
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [37] Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium
    Neyt, Mattias
    De laet, Chris
    Van Brabandt, Hans
    Franco, Oscar
    Ramaekers, Dirk
    [J]. ACTA CARDIOLOGICA, 2009, 64 (01) : 1 - 10
  • [38] Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia
    Pecenka, Clinton J.
    Johansson, Kjell Arne
    Memirie, Solomon Tessema
    Jamison, Dean T.
    Verguet, Stephane
    [J]. BMJ OPEN, 2015, 5 (04):
  • [39] Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis
    Boettiger, David C.
    Newall, Anthony T.
    Chattranukulchai, Pairoj
    Chaiwarith, Romanee
    Khusuwan, Suwimon
    Avihingsanon, Anchalee
    Phillips, Andrew
    Bendavid, Eran
    Law, Matthew G.
    Kahn, James G.
    Ross, Jeremy
    Bautista-Arredondo, Sergio
    Kiertiburanakul, Sasisopin
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23
  • [40] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. CIRCULATION, 2016, 134
12345